Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Ritsch

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Scientific Reports|March 30, 2020
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor AgonistsMaria Dumitrascuta, Marcel Bermudez, Tanila Ben Haddou, et al.
Atherosclerosis|June 8, 2007
Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosisWilfried Schgoer, Thomas Mueller, Matti Jauhiainen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2009
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevanceBarbara Messner, Michael Knoflach, Andreas Seubert, et al.
Atherosclerosis|April 13, 2012
Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbitsEgon Demetz, Ivan Tancevski, Kristina Duwensee, et al.
Journal of Molecular and Cellular Cardiology|August 8, 2016
Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- miceBernhard Scharinger, Barbara Messner, Adrian Türkcan, et al.
Metabolism: Clinical and Experimental|July 10, 2007
Scavenger receptor class B type I polymorphisms and peripheral arterial diseaseAndreas Ritsch, Gudrun Sonderegger, Gudron Sonderegger, et al.
Atherosclerosis|August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer proteinKristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Scientific Reports|November 6, 2020
HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns studyMonika Hunjadi, Claudia Lamina, Patrick Kahler, et al.
Atherosclerosis|September 19, 2020
Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery diseaseGünther Silbernagel, Hubert Scharnagl, Marcus E Kleber, et al.
International Journal of Obesity (2005)|January 15, 2022
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulationJulian Schwärzler, Lisa Mayr, Bernhard Radlinger, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Scientific Reports|March 30, 2020
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor AgonistsMaria Dumitrascuta, Marcel Bermudez, Tanila Ben Haddou, et al.
Atherosclerosis|June 8, 2007
Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosisWilfried Schgoer, Thomas Mueller, Matti Jauhiainen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2009
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevanceBarbara Messner, Michael Knoflach, Andreas Seubert, et al.
Atherosclerosis|April 13, 2012
Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbitsEgon Demetz, Ivan Tancevski, Kristina Duwensee, et al.
Journal of Molecular and Cellular Cardiology|August 8, 2016
Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- miceBernhard Scharinger, Barbara Messner, Adrian Türkcan, et al.
Metabolism: Clinical and Experimental|July 10, 2007
Scavenger receptor class B type I polymorphisms and peripheral arterial diseaseAndreas Ritsch, Gudrun Sonderegger, Gudron Sonderegger, et al.
Atherosclerosis|August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer proteinKristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Scientific Reports|November 6, 2020
HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns studyMonika Hunjadi, Claudia Lamina, Patrick Kahler, et al.
Atherosclerosis|September 19, 2020
Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery diseaseGünther Silbernagel, Hubert Scharnagl, Marcus E Kleber, et al.
International Journal of Obesity (2005)|January 15, 2022
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulationJulian Schwärzler, Lisa Mayr, Bernhard Radlinger, et al.
Pageof 7